ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,000,000 | +2773.6% | 203 | -98.0% | 0.10% | +33.3% |
| Q1 2022 | $348,000 | 0.0% | 10,000 | 0.0% | 0.08% | 0.0% |
| Q4 2021 | $348,000 | +28.4% | 10,000 | 0.0% | 0.08% | +20.0% |
| Q3 2021 | $271,000 | +4.6% | 10,000 | 0.0% | 0.06% | -4.4% |
| Q2 2021 | $259,000 | +19.9% | 10,000 | 0.0% | 0.07% | +19.3% |
| Q1 2021 | $216,000 | +0.5% | 10,000 | 0.0% | 0.06% | -3.4% |
| Q4 2020 | $215,000 | +45.3% | 10,000 | 0.0% | 0.06% | +22.9% |
| Q3 2020 | $148,000 | -34.8% | 10,000 | 0.0% | 0.05% | -36.0% |
| Q2 2020 | $227,000 | +62.1% | 10,000 | 0.0% | 0.08% | +17.2% |
| Q1 2020 | $140,000 | -14.1% | 10,000 | 0.0% | 0.06% | +8.5% |
| Q4 2019 | $163,000 | -53.4% | 10,000 | 0.0% | 0.06% | -63.6% |
| Q3 2019 | $350,000 | -60.5% | 10,000 | +17.6% | 0.16% | -53.0% |
| Q1 2018 | $885,000 | -48.3% | 8,500 | -50.0% | 0.34% | -42.8% |
| Q4 2017 | $1,711,000 | -38.7% | 17,000 | -83.1% | 0.60% | -43.5% |
| Q1 2017 | $2,789,000 | – | 100,500 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |